Selective inhibition of cathepsin B with cell-permeable CA074Me negatively affects L6 rat myoblast differentiation

Biochemistry and Cell Biology

Volumn 80, Issue 4, 2002, Pages 457-465

  Jane, Derek T ^a   Morvay, Leslie C ^a   Allen, Francis ^a   Sloane, Bonnie F ^a   Dufresne, Michael J ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

Author keywords

CA074Me; Cathepsin B; Myogenesis

Indexed keywords

BIOMARKERS; ENZYME INHIBITION; PROTEINS;

MYOGENESIS;

BIOCHEMISTRY;

CATHEPSIN B; CREATINE KINASE; ENZYME INHIBITOR; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL FUSION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOSE CALCULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE EXPRESSION; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN CONTENT; RAT;

ANIMALIA;

EID: 0036435967     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o02-134     Document Type: Article

References (26)

1. Bader, D., Masaki, T., and Fischman, D. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95: 763-770.
2. Bradford, M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein using the principal of protein dye binding. Anal. Biochem. 72: 248-254.
3. Buckingham, M. 2001. Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 4: 440-448.
4. Buttle, D.J., Murata, M., Knight, C.G., and Barrett, A.J. 1992. CA074 methyl ester: A proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299: 377-380.
5. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. 1998. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. U.S.A. 95: 4516-4521.
6. Dourdin, N., Brustis, J., Balcerzak, D., Elamrani, N., Poussard, S., Cottin, P., and Ducastaing, A. 1997. Myoblast fusion requires fibronectin degradation by exteriorized m-calpain. Exp. Cell Res. 235: 385-394.
7. Dufresne, M.J., Rogers, J., Coulter, M.B., Ball, E., Lo, T., and Sanwal, B.D. 1976. Apparent dominance of serine auxotrophy and the absence of expression of muscle-specific proteins in rat myoblast x mouse L-cell hybrids. Somatic Cell Genet. 2: 521-535.
8. Ebisui, C., Tsuujinaka, T., Kido, Y., Ijima, S., Yano, M., Shibata, H., Tanaka, T., and Mori, T. 1994. Role of intracellular proteases in differentiation of L6 myoblast cells. Biochem. Mol. Biol. Int. 32: 515-521.
9. Fernandez, C. and Sainz, R.D. 1997. Pathways of protein degredation in L6 myotubes. Proc. Soc. Exp. Biol. Med. 214: 242-247.
10. Guttridge, D., Lau, A., Tran, L., and Cunningham, D. 1997. Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed expression of myogenin and p21. J. Biol. Chem. 272: 24 117 - 24 210.
11. Hill, P.A., Murphy, G., Docherty, A.J., Hembry, R.M., Millican, T.A., Reynolds, J.J., and Meikle, M.C. 1994. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J. Cell Sci. 107: 3055-3064.
12. Huovila, A.P., Almeida, E.A., and White, J.M. 1996. ADAMS and cell fusion. Curr. Opin. Cell Biol. 8: 692-699.
13. Jane, D.T., and Dufresne, M.J. 1994. Expression and regulation of three lysosomal cysteine protease activities during growth of a differentiating L6 rat myoblast cell line and its non-fusing variant. Biochem. Cell Biol. 72: 267-274.
14. Jane, D.T., DaSilva, L., Koblinski, J., Horwitz, H., Sloane, B.F., and Dufresne, M.J. 2002. Evidence for the involvement of cathepsin B in skeletal muscle cell differentiation. J. Cell. Biochem. 84: 520-531.
15. Kim, S.S., Rhee, S., Lee, K.H., Kim, J.H., Kim, H.S., Kang, M.S., and Chung, C.H. 1998. Inhibitors of the proteosome block the myogenic differentiation of rat L6 myoblasts. FEBS Lett. 433: 47-50.
16. Kwak, K.B., Kambayashi, J., Kang, M.S., Ha, D.B., and Chung, C.H. 1993. Cell-penetrating inhibitors of calpain block both membrane fusion and filamin cleavage in chick embryonic myoblasts. FEBS Lett. 323: 151-154.
17. Mai, J., Finley, R.L., Waisman, D.M., and Sloane, B.F. 2000. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275: 12 806 - 12 812.
18. Matsuishi, M., Matsumoto, T., Okitani, A., and Kato, H. 1992. Mode of action of rabbit skeletal muscle cathepsin B towards myofibrillar proteins and myofibrillar structure. J. Biochem. 24: 1967-1978.
19. Mort, J.S., and Buttle, D.J. 1997. Molecules in focus: Cathepsin B. Int. J. Biochem. Cell Biol. 29: 715-720.
20. Munoz-Canoves, P., Miralles, F., Baiget, M., and Felez, J. 1997. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro. Thromb. Haemostasis, 77: 526-534.
21. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., and Katunuma, N. 1991. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280: 307-310.
22. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. 1998. Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus. Science (Washington, D.C.), 280: 450-453.
23. Spizz, G., and Blackshear, P.J. 1997. Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J. Biol. Chem. 272: 23 833 - 23 842.
24. Towatari, T., Nikawa, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., and Katanuma, N. 1991. Novel epoxysuccinyl peptides: A selective inhibitor of cathepsin B in vivo. FEBS Lett. 280: 311-315.
25. Wright, W.E., Binder, M., and Funk, W. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11: 4104-4110.
26. Yaffe, D. 1968. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. U. S. A. 61: 477-483.